New reports reveal the most commonly prescribed inhaler in the U.S. may actually be contributing to climate change. While these inhalers are critically important to saving lives and making it easier ...
Millions of Americans using inhaler sprays for chronic lung diseases, such as asthma, may be contributing to global pollution, according to new research. The study indicates that the propellants in ...
GAINESVILLE, Fla. --- A common asthma inhaler powered by a new propellant is safe and effective but could come at nearly triple the cost to consumers until a generic version hits the market, according ...
Climate change is making asthma worse, as hotter temperatures increase ozone pollution and wildfires and make pollen season longer. But asthma, ironically, is also making climate change worse: ...
Early fall is when asthma flare-ups peak in the US, and a warming climate is bad news for sufferers: It means more ground-level ozone, a longer pollen season and more wildfire smoke - all triggers for ...
Some doctors are promoting propellant-free inhalers over puff inhalers that emit greenhouse gases. Climate change can exacerbate respiratory ills... Could better asthma inhalers help patients, and the ...
NOW THAT THE EV TAX CREDIT IS GONE, THE MILLIONS OF AMERICANS WHO STRUGGLE WITH CHRONIC LUNG DISEASE, INCLUDING ASTHMA, MAY BE ADDING TO A GLOBAL ISSUE, ACCORDING TO NEW RESEARCH. MEDICATION INHALER ...
CHARLOTTE, N.C., Feb. 22, 2022 /PRNewswire/ -- Honeywell (Nasdaq: HON) today announced a commercial partnership with AstraZeneca (LON: AZN) to develop and bring to market next-generation respiratory ...
This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. The Food and Drug Administration said Tuesday it is taking a ...
(NEXSTAR) – That small whoosh from an inhaler has a substantial environmental toll that could be putting some people with chronic conditions at risk, according to a new study. Published Monday in the ...
BOSTON, Feb. 4, 2020 /PRNewswire/ -- Koura (previously known as Mexichem Fluor), a pioneer in the development of next generation propellants, today announced FDA approval to proceed to clinical trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback